231 related articles for article (PubMed ID: 25977137)
1. ICSH guidelines for the standardization of bone marrow immunohistochemistry.
Torlakovic EE; Brynes RK; Hyjek E; Lee SH; Kreipe H; Kremer M; McKenna R; Sadahira Y; Tzankov A; Reis M; Porwit A;
Int J Lab Hematol; 2015 Aug; 37(4):431-49. PubMed ID: 25977137
[TBL] [Abstract][Full Text] [Related]
2. ICSH guidelines for the standardization of bone marrow specimens and reports.
Lee SH; Erber WN; Porwit A; Tomonaga M; Peterson LC;
Int J Lab Hematol; 2008 Oct; 30(5):349-64. PubMed ID: 18822060
[TBL] [Abstract][Full Text] [Related]
3. Call for a European programme in external quality assurance for bone marrow immunohistochemistry; report of a European Bone Marrow Working Group pilot study.
Torlakovic EE; Naresh K; Kremer M; van der Walt J; Hyjek E; Porwit A
J Clin Pathol; 2009 Jun; 62(6):547-51. PubMed ID: 19474355
[TBL] [Abstract][Full Text] [Related]
4. Flow Cytometric Analysis of Mechanically Disaggregated Bone Marrow Trephine Biopsies.
Wheeler M; White G; Brockie S; Dickson M; Weinkove R
Cytometry B Clin Cytom; 2018 Nov; 94(6):935-940. PubMed ID: 30350400
[TBL] [Abstract][Full Text] [Related]
5. Modern techniques for the diagnostic evaluation of the trephine bone marrow biopsy: methodological aspects and applications.
Fend F; Tzankov A; Bink K; Seidl S; Quintanilla-Martinez L; Kremer M; Dirnhofer S
Prog Histochem Cytochem; 2008; 42(4):203-52. PubMed ID: 18243899
[TBL] [Abstract][Full Text] [Related]
6. Contribution of flow cytometric immunophenotyping and bone marrow trephine biopsy in the detection of lymphoid bone marrow infiltration in non-Hodgkin's lymphomas.
Mazur G; Hałoń A; Wróbel T; Jeleń M; Kuliczkowski K
Neoplasma; 2004; 51(3):159-63. PubMed ID: 15254666
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and classification of malignant lymphoma and related entities in the bone marrow trephine biopsy.
Fend F; Kremer M
Pathobiology; 2007; 74(2):133-43. PubMed ID: 17587884
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence in situ hybridisation analysis of bone marrow trephine biopsy specimens; an additional tool in the diagnostic armoury.
Neat MJ; Moonim MT; Dunn RG; Geoghegan H; Foot NJ
J Clin Pathol; 2013 Jan; 66(1):54-7. PubMed ID: 23038690
[TBL] [Abstract][Full Text] [Related]
9. Assessment of bone marrow involvement in patients with lymphoma: report on a consensus meeting of the Korean Society of Hematology Lymphoma Working Party.
Park Y; Park BB; Jeong JY; Kim WY; Jang S; Shin BK; Lee DS; Han JH; Park CJ; Suh C; Kim I; Chi HS
Korean J Intern Med; 2016 Nov; 31(6):1030-1041. PubMed ID: 27809449
[TBL] [Abstract][Full Text] [Related]
10. [Fixation and decalcification in trephination biopsy].
Fakan F; Skálová A
Cesk Patol; 1994 Aug; 30(3):103-5. PubMed ID: 7923418
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow involvement in follicular lymphoma: comparison of histology and flow cytometry as staging procedures.
Schmidt B; Kremer M; Götze K; John K; Peschel C; Höfler H; Fend F
Leuk Lymphoma; 2006 Sep; 47(9):1857-62. PubMed ID: 17064998
[TBL] [Abstract][Full Text] [Related]
12. The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.
Xubo G; Xingguo L; Xianguo W; Rongzhen X; Xibin X; Lin W; Lei Z; Xiaohong Z; Genbo X; Xiaoying Z
Eur J Haematol; 2009 Oct; 83(4):292-301. PubMed ID: 19500135
[TBL] [Abstract][Full Text] [Related]
13. Optimal processing of bone marrow trephine biopsy: the Hammersmith Protocol.
Naresh KN; Lampert I; Hasserjian R; Lykidis D; Elderfield K; Horncastle D; Smith N; Murray-Brown W; Stamp GW
J Clin Pathol; 2006 Sep; 59(9):903-11. PubMed ID: 16935969
[TBL] [Abstract][Full Text] [Related]
14. ICSH: on board for new projects.
Zini G; Kern W; Brereton M; Stephens AD
Int J Lab Hematol; 2014 Jun; 36(3):306-12. PubMed ID: 24750677
[TBL] [Abstract][Full Text] [Related]
15. The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cells.
Ng AP; Wei A; Bhurani D; Chapple P; Feleppa F; Juneja S
Haematologica; 2006 Jul; 91(7):972-5. PubMed ID: 16818287
[TBL] [Abstract][Full Text] [Related]
16. Making the most of bone marrow trephine biopsy.
Wilkins BS; Clark DM
Histopathology; 2009 Dec; 55(6):631-40. PubMed ID: 19878351
[TBL] [Abstract][Full Text] [Related]
17. Vortex-dislodged cells from bone marrow trephine biopsy yield satisfactory results for flow cytometric immunophenotyping.
Bommannan K; Sachdeva MU; Gupta M; Bose P; Kumar N; Sharma P; Naseem S; Ahluwalia J; Das R; Varma N
Int J Lab Hematol; 2016 Oct; 38(5):543-9. PubMed ID: 27339905
[TBL] [Abstract][Full Text] [Related]
18. Quality control of flow cytometry data analysis for evaluation of minimal residual disease in bone marrow from acute leukemia patients during treatment.
Björklund E; Matinlauri I; Tierens A; Axelsson S; Forestier E; Jacobsson S; Ahlberg AJ; Kauric G; Mäntymaa P; Osnes L; Penttilä TL; Marquart H; Savolainen ER; Siitonen S; Torikka K; Mazur J; Porwit A
J Pediatr Hematol Oncol; 2009 Jun; 31(6):406-15. PubMed ID: 19648789
[TBL] [Abstract][Full Text] [Related]
19. Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS - part II - preanalytical issues.
Davis BH; Dasgupta A; Kussick S; Han JY; Estrellado A;
Cytometry B Clin Cytom; 2013; 84(5):286-90. PubMed ID: 24022851
[TBL] [Abstract][Full Text] [Related]
20. A retrospective study to assess the relative value of peripheral blood, bone marrow aspirate and biopsy morphology, immunohistochemical stains, and flow cytometric analysis in the diagnosis of chronic B cell lymphoproliferative neoplasms.
Zhang QY; Chabot-Richards D; Evans M; Spengel K; Andrews J; Kang H; Foucar K
Int J Lab Hematol; 2015 Jun; 37(3):390-402. PubMed ID: 25307888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
